Secukinumab was efficacious in the treatment of moderate to severe plaque psoriasis in the North American population: Pooled analysis of phase III studies

Secukinumab was efficacious in the treatment of moderate to severe plaque psoriasis in the North American population: Pooled analysis of phase III studies Meeting Abstract

publication date

May 1, 2015

webpage

Web of Science

published in

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY Journal

start page

AB251

end page

AB251

volume

72

issue

5